← Leaderboards
George F Murphy
Brigham And Women'S Hospital
$7,377,470
Attributed
$9,728,263
Total exposure
15
Grants
13
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,730,687 · 16
By mechanism
P01$12,582,742 · 9
R01$5,463,276 · 4
U19$604,917 · 1
P30$79,752 · 2
Top collaborators
- Markus H. Frank13 shared
- Frank S Hodi5 shared
- Natasha Y Frank4 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Markus H. Frank$10,452,698
- Gregory L Stahl$14,189,628
- Christine Guo Lian$2,178,309
- Natasha Y Frank$4,964,719
- Anny Xiaobo Zhou$14,633,236
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsCellsResearch PersonnelTissuesTechnologyReceptorAffectSkinStem CellsSitePathologyDesignSynergismResolutionIn VivoMalignant NeoplasmsT-LymphocyteLabelResourcesChronicMolecularImmunityProtocols DocumentationHistology
Grant awards (45)
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency$2,187,178
P01 · FY2025 · AG · contact PI
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$413,768
R01 · FY2025 · HL · contact PI
Core C Cell and Tissue Imaging and Analysis$364,530
P01 · FY2025 · AG · contact PI
Core A Administrative Core$364,530
P01 · FY2025 · AG · contact PI
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency$2,231,814
P01 · FY2024 · AG · contact PI
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$405,493
R01 · FY2024 · HL · contact PI
Core C Cell and Tissue Imaging and Analysis$231,119
P01 · FY2024 · AG · contact PI
Core A Administrative Core$176,340
P01 · FY2024 · AG · contact PI
Core D - Immunopathology$160,375
P01 · FY2024 · AI · contact PI
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency$2,231,812
P01 · FY2023 · AG · contact PI
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$413,768
R01 · FY2023 · HL · contact PI
Core C Cell and Tissue Imaging and Analysis$231,119
P01 · FY2023 · AG · contact PI
Core A Administrative Core$176,340
P01 · FY2023 · AG · contact PI
Core D - Immunopathology$160,375
P01 · FY2023 · AI · contact PI
Multicomponent Therapy for Age-related Skin Stem Cell Deficiency$2,351,620
P01 · FY2022 · AG · contact PI
Skin-Intrinsic Immunosuppressive Mesenchymal Stem Cells and aGVHD$433,517
R01 · FY2022 · HL · contact PI
Core C Cell and Tissue Imaging and Analysis$256,283
P01 · FY2022 · AG · contact PI
Core A Administrative Core$195,073
P01 · FY2022 · AG · contact PI
Core D - Immunopathology$160,375
P01 · FY2022 · AI · contact PI
Core D - Immunopathology$160,375
P01 · FY2021 · AI · contact PI
Core D - Immunopathology$174,498
P01 · FY2020 · AI · contact PI
Immunohistopathology Core$116,567
P01 · FY2019 · AI · contact PI
Immunohistopathology Core$197,471
P01 · FY2018 · AI · contact PI
Immunohistopathology Core$120,268
P01 · FY2017 · AI · contact PI
Immunology of human malignant melanoma initiating cells$364,127
R01 · FY2016 · CA
Immunohistopathology Core$183,866
P01 · FY2016 · AI · contact PI
Immunology of human malignant melanoma initiating cells$364,127
R01 · FY2015 · CA
Immunohistopathology Core$150,814
P01 · FY2015 · AI · contact PI
Immunology of human malignant melanoma initiating cells$353,203
R01 · FY2014 · CA
Immunology of human malignant melanoma initiating cells$377,059
R01 · FY2013 · CA
Immunology of human malignant melanoma initiating cells$401,127
R01 · FY2012 · CA
Cellular Pathology of Graft Versus Host Disease$297,369
R01 · FY2010 · HL · contact PI
Cellular Pathology of Graft Versus Host Disease$297,369
R01 · FY2009 · HL · contact PI
Evaluate the Effects of Experimental GVHD in Tissue$140,782
U19 · FY2009 · AI · contact PI
Cellular Pathology of Graft Versus Host Disease$297,369
R01 · FY2008 · HL · contact PI
Evaluate the Effects of Experimental GVHD in Tissue$139,112
U19 · FY2008 · AI · contact PI
Morphology and Cell Analysis Core$41,687
P30 · FY2008 · AR · contact PI
Cellular Pathology of Graft Versus Host Disease$297,369
R01 · FY2007 · HL · contact PI
Evaluate the Effects of Experimental GVHD in Tissue$139,177
U19 · FY2007 · AI · contact PI
Morphology and Cell Analysis Core$38,065
P30 · FY2007 · AR · contact PI
Cellular Pathology of Graft Versus Host Disease$306,250
R01 · FY2006 · HL · contact PI
Evaluate the Effects of Experimental GVHD in Tissue$127,370
U19 · FY2006 · AI · contact PI
Evaluate the Effects of Experimental GVHD in Tissue$58,476
U19 · FY2005 · AI
CELLULAR PATHOLOGY OF GRAFT VERSUS HOST DISEASE$222,844
R01 · FY2001 · CA
CELLULAR PATHOLOGY OF GRAFT VERSUS HOST DISEASE$218,517
R01 · FY2000 · CA